Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 20/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7383614 | 0.88 | ELANE (0.61) | ELANE | |
| SCHEMBL7383201 | 0.85 | ELANE (0.72) | ELANE | |
| SCHEMBL7386749 | 0.85 | ELANE (0.53) | ELANE | |
| SCHEMBL7388488 | 0.81 | ELANE (0.59) | ELANE | |
| SCHEMBL8810134 | 0.80 | ELANE (0.44) | ELANE | |
| SCHEMBL7382359 | 0.79 | ELANE (0.80) | ELANE | |
| SCHEMBL7381092 | 0.78 | ELANE (0.60) | ELANE | |
| SCHEMBL7279352 | 0.78 | ELANE (0.74) | ELANE | |
| SCHEMBL7309727 | 0.78 | ELANE (0.61) | ELANE | |
| SCHEMBL8813754 | 0.78 | ELANE (0.58) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5296496-A | Treating degenerative diseases | STERLING WINTHROP INC. (US) | 1994-03-22 | — | — | US | disclosed |
| EP-0549073-A1 | Novel 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1993-06-30 | — | — | EP | disclosed |
| US-5187173-A | Degenerative diseases such as emphysema, rheumatoid arthritis, pancreatitis, cyctic fibrosis and skin disorders | STERLING WINTHROP INC. (US) | 1993-02-16 | — | — | US | disclosed |